Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
CSL Behring is seeking a Principal Scientist, CMC to act as a senior scientific SME for Chemistry, Manufacturing and Controls supporting innovative biologics. The role provides expert technical assessment, guidance, and risk-based recommendations to program teams spanning Development, Technical Operations, Quality, Regulatory, Clinical Development, Supply Chain, and external partners.
Deep CMC expertise in cell/gene therapy is required.
The Principal Scientist, CMC serves as a senior scientific subject matter expert for Chemistry, Manufacturing and Controls activities supporting innovative biologics. The role provides expert technical assessment, scientific guidance, and risk-based recommendations to program teams working across Development, Technical Operations, Quality, Regulatory, Clinical Development, Supply Chain, and external development and manufacturing partners. The position requires deep CMC expertise, with particular strength in cell and gene therapy and/or cell-based technologies. Familiarity with advanced or emerging therapeutic modalities and manufacturing platforms is a plus and may help the candidate contribute to programs where technologies, processes, and development expectations are evolving.
Applies deep scientific and technical expertise to CMC strategy discussions for innovative biologics, including process development, analytical development, characterization, manufacturing, technology transfer, stability, control strategy, and lifecycle management.
Develops data-driven technical recommendations and fit-for-purpose approaches appropriate to the stage and complexity of each program, balancing scientific rationale, regulatory expectations, quality requirements, supply needs, timelines, and business priorities.
Serves as a subject matter expert for cell and gene therapy and cell-based therapeutic platforms; familiarity with AAV or other viral vectors, baculovirus-based expression systems, insect cell platforms, oligonucleotides, nucleic acid-based therapeutics, or other emerging modalities is a plus.
Provides expert technical input and scientific oversight for work conducted with external development and manufacturing partners, including CDMOs, CROs, technology providers, and strategic collaborators; supports technical scope definition, deliverable review, issue investigation, and risk mitigation.
Participates as a senior CMC expert on cross-functional program teams and partners with Process Development, Analytical Development, Quality, Regulatory CMC, Manufacturing, Supply Chain, Engineering, Clinical Development, and other functions to ensure technical considerations are evaluated and communicated clearly.
Strengthens organizational capability by sharing platform knowledge, advancing scientific standards and technical practices, evaluating external innovation, mentoring colleagues, and promoting scientific rigor, collaboration, accountability, and continuous improvement.
The expected base salary range for this position at hiring is $179,000 - $212,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed location as of the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL .
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .